Interleukin-8 is a paracrine inducer of fibroblast growth factor 2, a stromal and epithelial growth factor in benign prostatic hyperplasia.

[1]  M. Ittmann,et al.  Interleukin-1α Is a Paracrine Inducer of FGF7, a Key Epithelial Growth Factor in Benign Prostatic Hyperplasia , 2000 .

[2]  C. Dinney,et al.  Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[3]  M. Ittmann,et al.  Interleukin-1alpha is a paracrine inducer of FGF7, a key epithelial growth factor in benign prostatic hyperplasia. , 2000, American Journal of Pathology.

[4]  M. Ittmann,et al.  FGF7 and FGF2 are increased in benign prostatic hyperplasia and are associated with increased proliferation. , 1999, The Journal of urology.

[5]  Antonin Morillon,et al.  Expression of Human Fibroblast Growth Factor 2 mRNA Is Post-transcriptionally Controlled by a Unique Destabilizing Element Present in the 3′-Untranslated Region between Alternative Polyadenylation Sites* , 1999, The Journal of Biological Chemistry.

[6]  M. Ittmann,et al.  FGF9 is an autocrine and paracrine prostatic growth factor expressed by prostatic stromal cells , 1999, Journal of cellular physiology.

[7]  M. Sabbieti,et al.  Parathyroid Hormone Regulates the Expression of Fibroblast Growth Factor‐2 mRNA and Fibroblast Growth Factor Receptor mRNA in Osteoblastic Cells , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[8]  M. Burdick,et al.  Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells. , 1999, The American journal of pathology.

[9]  M. Ittmann,et al.  Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[10]  F. Gage,et al.  Repression of Human Fibroblast Growth Factor 2 by a Novel Transcription Factor* , 1999, The Journal of Biological Chemistry.

[11]  Downey,et al.  Asymptomatic inflammation and/or infection in benign prostatic hyperplasia , 1999, BJU international.

[12]  E. Kardami,et al.  alpha1-Adrenergic stimulation of FGF-2 promoter in cardiac myocytes and in adult transgenic mouse hearts. , 1999, American Journal of Physiology.

[13]  E. Kardami,et al.  α1-Adrenergic stimulation of FGF-2 promoter in cardiac myocytes and in adult transgenic mouse hearts. , 1999, American journal of physiology. Heart and circulatory physiology.

[14]  J. Anim,et al.  Characterisation of inflammatory cells in benign prostatic hyperplasia. , 1998, Acta histochemica.

[15]  A. Nel,et al.  Inflammatory cytokines induce the expression of basic fibroblast growth factor (bFGF) isoforms required for the growth of Kaposi's sarcoma and endothelial cells through the activation of AP‐1 response elements in the bFGF promoter , 1998, AIDS.

[16]  P. Proost,et al.  Interleukin-8 and other CXC chemokines , 1998 .

[17]  V. Laudone,et al.  Angiogenesis and prostate cancer: in vivo and in vitro expression of angiogenesis factors by prostate cancer cells. , 1998, Urology.

[18]  D. Kelvin,et al.  Regulation of CCR2 chemokine receptor mRNA stability , 1997, Journal of leukocyte biology.

[19]  E. Wijelath,et al.  Oncostatin M induces basic fibroblast growth factor expression in endothelial cells and promotes endothelial cell proliferation, migration and spindle morphology. , 1997, Journal of cell science.

[20]  M. Ittman,et al.  Expression of fibroblast growth factors (FGFs) and FGF receptors in human prostate. , 1997, The Journal of urology.

[21]  N. Kyprianou,et al.  Apoptotic versus proliferative activities in human benign prostatic hyperplasia. , 1996, Human pathology.

[22]  H. Klocker,et al.  Regulation of prostatic growth and function by peptide growth factors , 1996, The Prostate.

[23]  C. Kevil,et al.  Translational enhancement of FGF-2 by eIF-4 factors, and alternate utilization of CUG and AUG codons for translation initiation. , 1995, Oncogene.

[24]  D. Taub,et al.  Granulocyte-Colony Stimulating Factor and Lipopolysaccharide Regulate the Expression of Interleukin 8 Receptors on Polymorphonuclear Leukocytes (*) , 1995, The Journal of Biological Chemistry.

[25]  E. Shapiro,et al.  Regional concentration of basic fibroblast growth factor in normal and benign hyperplastic human prostates. , 1995, The Journal of urology.

[26]  A. Thomson.  The cytokine handbook , 1994 .

[27]  E. Sherwood,et al.  Basic fibroblast growth factor: a potential mediator of stromal growth in the human prostate. , 1992, Endocrinology.

[28]  M. Jaye,et al.  Increased expression of genes for basic fibroblast growth factor and transforming growth factor type β2 in human benign prostatic hyperplasia , 1990, The Prostate.

[29]  J. L. Swain,et al.  Acidic fibroblast growth factor mRNA is expressed by cardiac myocytes in culture and the protein is localized to the extracellular matrix. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[30]  R J Glynn,et al.  The development of benign prostatic hyperplasia among volunteers in the Normative Aging Study. , 1985, American journal of epidemiology.